Liane McCarroll, MS, CCC-SLP/L

This physician is not currently rated. Why?

Why is this doctor not rated?


To ensure the accuracy of our patient satisfaction scores, we require that providers who see patients receive a minimum number of completed patient-submitted surveys before their reviews are listed on their profiles. Star ratings on this site are collected on a rolling basis from the previous 12 months.
Additionally, some of the physicians listed on our site do not see patients directly, and therefore, do not receive evaluation and ratings from patients.

More about patient ratings

Assistant Research Professor
Senior Speech Pathologist
Fox Chase Cancer Center
Department of Otolaryngology-Head & Neck Surgery, Lewis Katz School of Medicine, Temple University


Treatment Focus

Oral Cancer; Laryngeal and Hypopharyngeal Cancers; Oropharyngeal Cancer

  • Specialized skills include Videofluoroscopic Swallowing Studies, Fiberoptic Endoscopic Examination of Swallowing, Video Stroboscopy, and alaryngeal communication including management of Tracheo-esophageal Punctures (TEP). 
  • Also works in the Multidisciplinary Voice and Swallow Clinic. She is an advisor to “The SpeakEezy Club for larngectomees" and “The Head and Neck Cancer Support Group” at Fox Chase Cancer Center.

Clinical Locations

Educational Background

  • MS, Speech-Language Pathology, LaSalle University, Philadelphia, PA, 2010
  • BS, Speech-Language-Hearing Science, LaSalle University, Philadelphia, PA, 2009


  • STAR Certified - Survivorship Training and Rehabilitation
  • MBSImP Registered Clinician


  • American Speech Language and Hearing Association (ASHA)
  • ASHA Special Interest Group 03 - Voice and Voice Disorders
  • ASHA Special Interest Group 13 - Swallowing and Swallowing Disorders
  • International Association of Laryngectomee's (IAL)

Research Interests

  • Dysphagia
  • Dysphonia
  • Head and Neck Cancer Rehabilitation
  • Survivorship

Selected Publications

Book Chapters:

McCarroll L, Ebersole B. The role of voice therapy in managing laryngopharyngeal reflux. In Jamal N, Wang M, eds: Laryngopharyngeal Reflux Disease: Integrative Approaches. Philadelphia, PA: Springer Nature, SPi Global publishers; 2018 IN PRESS.

Published Articles:

Sulibhavi, A., Tharmalingam, S., McCarroll, L., Soliman, A. Reversible bevacizumab induced vocal fold necrosis. Journal of Voice 2020 Dec 21: S0892-1997(20)30431-8. doi: 10.1016/j.jvoice.2020.11.028. Epub ahead of print. PMID: 33358072.

Ebersole, B., McCarroll, L., Ridge J., Liu, J., Bauman, J., Donnelly, S., Galloway, T. Identification and Management of Late Dysfunction in Survivors of Head and Neck Cancer: Implementation and Outcomes of an Interdisciplinary Quality of Life (IQOL) Clinic. Head and Neck. 2021; 1-12.

Accepted Abstracts - Oral Presentations:

Sulibhavi, A, Tharmalingam, S, McCarroll, L, Soliman, A. “Reversible Bevacizumab-Induced Vocal Fold Necrosis”. Oral presentation at Virtual Annual Meeting of the Pennsylvania Academy of Otolaryngology June 13th, 2020.

Ebersole B, McCarroll L, Lango M, Ridge J, Liu J, Schmalbach C. Dysphagia Following Total Laryngectomy: When to treat with dysphagia therapy? A case study. Oral Presentation. 2019 Head and Neck Cancer Survivorship Symposium, Pittsburgh, PA. August 5-6 2019.